Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

• Status: Unknown status
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A study of pharmacokinetics of daily intravenous busulfan

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alberta Health Services
• Treatments: Busulfan; Fludarabine; Fludarabine phosphate

Criteria

Inclusion Criteria:

• patients undergoing transplantation

Exclusion Criteria:

-